In addition, it addresses the FDA’s communications with the applicant, the retention of information that guidance the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer ownership of the SE report to a different applicant and electronic submission of your SE report and ame